US Stock MarketDetailed Quotes

MBRX Moleculin Biotech

Watchlist
  • 2.3200
  • -0.1400-5.69%
Close Dec 13 16:00 ET
  • 2.1800
  • -0.1400-6.03%
Post 20:01 ET
6.96MMarket Cap-0.19P/E (TTM)

Moleculin Biotech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
19.04%-6.11M
-16.06%-5.95M
-11.63%-6.72M
12.80%-24.1M
25.48%-5.41M
0.34%-7.55M
35.93%-5.13M
-25.22%-6.02M
-45.84%-27.64M
-70.41%-7.26M
Net income from continuing operations
-88.84%-10.59M
27.73%-4.32M
37.21%-4.97M
-2.56%-29.77M
-51.68%-10.27M
34.86%-5.61M
11.82%-5.98M
-15.26%-7.92M
-82.62%-29.03M
-139.65%-6.77M
Operating gains losses
257,600.00%2.58M
-4,611.11%-1.7M
-3,630.77%-1.46M
178.20%1.04M
841.72%1.12M
99.76%-1K
94.03%-36K
75.63%-39K
80.16%-1.34M
93.43%-151K
Depreciation and amortization
3.23%32K
0.00%31K
6.67%32K
-2.31%127K
9.38%35K
-3.13%31K
-8.82%31K
-6.25%30K
-20.73%130K
-5.88%32K
Other non cash items
99,000.00%991K
--0
-87.76%108K
868.48%891K
450.00%14K
-91.67%1K
0.00%-6K
880.00%882K
-4.17%92K
33.33%-4K
Change In working capital
121.41%528K
-220.11%-418K
-275.86%-925K
624.11%1.62M
457.91%3.21M
-446.35%-2.47M
129.92%348K
-66.56%526K
-78.42%224K
-417.31%-898K
-Change in prepaid assets
272.28%685K
36.40%-753K
38.17%590K
68.26%-272K
-53.69%301K
-17.12%184K
45.36%-1.18M
-2.51%427K
-298.84%-857K
118.12%650K
-Change in payables and accrued expense
94.08%-157K
-78.13%335K
-1,630.30%-1.52M
75.21%1.89M
288.18%2.91M
-640.82%-2.65M
52.59%1.53M
-91.28%99K
78.09%1.08M
-10,220.00%-1.55M
Cash from discontinued investing activities
Operating cash flow
19.04%-6.11M
-16.06%-5.95M
-11.63%-6.72M
12.80%-24.1M
25.48%-5.41M
0.34%-7.55M
35.93%-5.13M
-25.22%-6.02M
-45.84%-27.64M
-70.41%-7.26M
Investing cash flow
Cash flow from continuing investing activities
0
-85.07%-124K
-81K
-28K
-252.63%-67K
0
Net PPE purchase and sale
--0
----
----
-85.07%-124K
---81K
---28K
----
----
-252.63%-67K
--0
Cash from discontinued investing activities
Investing cash flow
--0
----
----
-85.07%-124K
---81K
---28K
----
----
-252.63%-67K
--0
Financing cash flow
Cash flow from continuing financing activities
116,575.00%4.66M
-151.02%-25K
0
20,321.74%4.65M
4.47M
63.64%-4K
508.33%49K
141K
-100.03%-23K
0
Net common stock issuance
--4.66M
--0
--0
--4.17M
--3.96M
--0
--70K
--141K
--0
--0
Net other financing activities
75.00%-1K
----
----
2,208.70%485K
--510K
63.64%-4K
----
----
0.00%-23K
--0
Cash from discontinued financing activities
Financing cash flow
116,575.00%4.66M
-151.02%-25K
--0
20,321.74%4.65M
--4.47M
63.64%-4K
508.33%49K
--141K
-100.03%-23K
--0
Net cash flow
Beginning cash position
-66.29%10.85M
-54.85%16.82M
-45.42%23.55M
-39.15%43.15M
-51.22%24.58M
-44.53%32.17M
-43.63%37.27M
-39.15%43.15M
367.30%70.9M
-32.97%50.39M
Current changes in cash
80.83%-1.45M
-17.58%-5.99M
-14.31%-6.72M
29.41%-19.57M
85.90%-1.02M
0.07%-7.58M
36.93%-5.09M
-22.14%-5.88M
-149.73%-27.73M
-69.65%-7.26M
Effect of exchange rate changes
240.00%14K
900.00%8K
-125.00%-9K
27.59%-21K
-166.67%-6K
47.37%-10K
96.77%-1K
-133.33%-4K
-20.83%-29K
350.00%9K
End cash Position
-61.74%9.41M
-66.29%10.85M
-54.85%16.82M
-45.42%23.55M
-45.42%23.55M
-51.22%24.58M
-44.53%32.17M
-43.63%37.27M
-39.15%43.15M
-39.15%43.15M
Free cash flow
19.34%-6.11M
-15.97%-5.96M
-11.63%-6.72M
12.56%-24.23M
24.37%-5.49M
-0.03%-7.58M
36.23%-5.14M
-25.07%-6.02M
-46.05%-27.71M
-69.65%-7.26M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 19.04%-6.11M-16.06%-5.95M-11.63%-6.72M12.80%-24.1M25.48%-5.41M0.34%-7.55M35.93%-5.13M-25.22%-6.02M-45.84%-27.64M-70.41%-7.26M
Net income from continuing operations -88.84%-10.59M27.73%-4.32M37.21%-4.97M-2.56%-29.77M-51.68%-10.27M34.86%-5.61M11.82%-5.98M-15.26%-7.92M-82.62%-29.03M-139.65%-6.77M
Operating gains losses 257,600.00%2.58M-4,611.11%-1.7M-3,630.77%-1.46M178.20%1.04M841.72%1.12M99.76%-1K94.03%-36K75.63%-39K80.16%-1.34M93.43%-151K
Depreciation and amortization 3.23%32K0.00%31K6.67%32K-2.31%127K9.38%35K-3.13%31K-8.82%31K-6.25%30K-20.73%130K-5.88%32K
Other non cash items 99,000.00%991K--0-87.76%108K868.48%891K450.00%14K-91.67%1K0.00%-6K880.00%882K-4.17%92K33.33%-4K
Change In working capital 121.41%528K-220.11%-418K-275.86%-925K624.11%1.62M457.91%3.21M-446.35%-2.47M129.92%348K-66.56%526K-78.42%224K-417.31%-898K
-Change in prepaid assets 272.28%685K36.40%-753K38.17%590K68.26%-272K-53.69%301K-17.12%184K45.36%-1.18M-2.51%427K-298.84%-857K118.12%650K
-Change in payables and accrued expense 94.08%-157K-78.13%335K-1,630.30%-1.52M75.21%1.89M288.18%2.91M-640.82%-2.65M52.59%1.53M-91.28%99K78.09%1.08M-10,220.00%-1.55M
Cash from discontinued investing activities
Operating cash flow 19.04%-6.11M-16.06%-5.95M-11.63%-6.72M12.80%-24.1M25.48%-5.41M0.34%-7.55M35.93%-5.13M-25.22%-6.02M-45.84%-27.64M-70.41%-7.26M
Investing cash flow
Cash flow from continuing investing activities 0-85.07%-124K-81K-28K-252.63%-67K0
Net PPE purchase and sale --0---------85.07%-124K---81K---28K---------252.63%-67K--0
Cash from discontinued investing activities
Investing cash flow --0---------85.07%-124K---81K---28K---------252.63%-67K--0
Financing cash flow
Cash flow from continuing financing activities 116,575.00%4.66M-151.02%-25K020,321.74%4.65M4.47M63.64%-4K508.33%49K141K-100.03%-23K0
Net common stock issuance --4.66M--0--0--4.17M--3.96M--0--70K--141K--0--0
Net other financing activities 75.00%-1K--------2,208.70%485K--510K63.64%-4K--------0.00%-23K--0
Cash from discontinued financing activities
Financing cash flow 116,575.00%4.66M-151.02%-25K--020,321.74%4.65M--4.47M63.64%-4K508.33%49K--141K-100.03%-23K--0
Net cash flow
Beginning cash position -66.29%10.85M-54.85%16.82M-45.42%23.55M-39.15%43.15M-51.22%24.58M-44.53%32.17M-43.63%37.27M-39.15%43.15M367.30%70.9M-32.97%50.39M
Current changes in cash 80.83%-1.45M-17.58%-5.99M-14.31%-6.72M29.41%-19.57M85.90%-1.02M0.07%-7.58M36.93%-5.09M-22.14%-5.88M-149.73%-27.73M-69.65%-7.26M
Effect of exchange rate changes 240.00%14K900.00%8K-125.00%-9K27.59%-21K-166.67%-6K47.37%-10K96.77%-1K-133.33%-4K-20.83%-29K350.00%9K
End cash Position -61.74%9.41M-66.29%10.85M-54.85%16.82M-45.42%23.55M-45.42%23.55M-51.22%24.58M-44.53%32.17M-43.63%37.27M-39.15%43.15M-39.15%43.15M
Free cash flow 19.34%-6.11M-15.97%-5.96M-11.63%-6.72M12.56%-24.23M24.37%-5.49M-0.03%-7.58M36.23%-5.14M-25.07%-6.02M-46.05%-27.71M-69.65%-7.26M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------------Unqualified Opinion--
Heat List
US
Overall
Symbol
Price
% Chg

No Data